{"url_path":"/sec/vxrt/8-k/2026-07-17/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-17","source_url":"https://www.sec.gov/Archives/edgar/data/72444/0001437749-26-023762-index.html","accession_number":"0001437749-26-023762","cik":"0000072444","ticker":"VXRT","issuer_name":"Vaxart, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/72444/0001437749-26-023762-index.html","primary_entity_key":"0000072444","primary_entity_name":"Vaxart, Inc."},"word_count":314,"has_tables":true,"body_markdown":"**Item 5.07**\n\n**Submission of Matters to a Vote of Security Holders.**\n\n \n\nOn July 16, 2026, Vaxart, Inc. (the “Company”) held the Company’s 2026 annual meeting of stockholders (the “Annual Meeting”). Proxies had been submitted by stockholders representing approximately 45.7% of the shares of the Company’s common stock outstanding and entitled to vote, which constituted a quorum. At the Annual Meeting, the Company’s stockholders voted on three Proposals, each of which is described in more detail in the proxy statement for the Annual Meeting (the “Proxy Statement”).\n\n \n\nThe following is a brief description of each matter voted upon and the results, including the number of votes cast for and against each matter and, if applicable, the number of abstentions and broker non-votes with respect to each matter. Proxies for the Annual Meeting were solicited pursuant to Section 14(a) of the Securities Exchange Act of 1934, as amended.\n\n \n\n*Proposal 1*. Stockholders elected the six nominees for directors to serve until the Company’s 2027 annual meeting of stockholders or until their successors are duly elected and qualified. The voting results were as follows:\n\n \n\n**Director Name**\n\n \n\n**Votes For**\n\n \n\n**Votes Withheld**\n\n \n\n**Broker Non-Votes**\n\nJames B. Breitmeyer, M.D., Ph.D.\n\n \n\n86,985,391\n\n \n\n13,060,491\n\n \n\n10,585,218\n\nKevin P. Finney\n\n \n\n80,409,424\n\n \n\n19,636,458\n\n \n\n10,585,218\n\nElaine J. Heron, Ph.D.\n\n \n\n51,372,172\n\n \n\n48,672,711\n\n \n\n10,586,217\n\nSteven Lo\n\n \n\n50,272,817\n\n \n\n49,772,065\n\n \n\n10,586,218\n\nW. Mark Watson, C.P.A.\n\n \n\n77,497,037\n\n \n\n22,548,845\n\n \n\n10,585,218\n\nDavid Wheadon, M.D.\n\n \n\n51,931,124\n\n \n\n48,113,758\n\n \n\n10,586,218\n\n \n\n*Proposal 2*. Stockholders ratified the selection by the Audit Committee of WithumSmith+Brown, PC as the Company’s independent registered public accounting firm for the year ending December 31, 2026. The voting results were as follows:\n\n \n\n**Votes For**\n\n \n\n**Votes Against**\n\n \n\n**Abstentions**\n\n \n\n**Broker Non-Votes**\n\n80,448,931\n\n \n\n19,724,442\n\n \n\n10,457,727\n\n \n\n-\n\n \n\n*Proposal 3*. Stockholders did not approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. The voting results were as follows:\n\n \n\n**Votes For**\n\n \n\n**Votes Against**\n\n \n\n**Abstentions**\n\n \n\n**Broker Non-Votes**\n\n46,024,068\n\n \n\n51,842,781\n\n \n\n2,300,962\n\n \n\n10,463,289"}